We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
-0.15%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.32B
AUM Growth
-$178M
Cap. Flow
-$136M
Cap. Flow %
-10.34%
Top 10 Hldgs %
31.24%
Holding
150
New
40
Increased
28
Reduced
30
Closed
36

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.2M
2
STWD icon
Starwood Property Trust
STWD
+$29.1M
3
AAPL icon
Apple
AAPL
+$28.7M
4
KMI icon
Kinder Morgan
KMI
+$28.2M
5
XOM icon
ExxonMobil
XOM
+$27.2M

Top Sells

Rank Stock Value
1
PFSI icon
PennyMac Financial
PFSI
+$79.8M
2
MU icon
Micron Technology
MU
+$59.6M
3
FNF icon
Fidelity National Financial
FNF
+$57.3M
4
TSLA icon
Tesla
TSLA
+$43.4M
5
TSM icon
TSMC
TSM
+$38.3M

Sector Composition

Rank Sector Weight
1 Healthcare 26.85%
2 Technology 19.68%
3 Consumer Discretionary 11.95%
4 Miscellaneous 9.52%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LITE icon
51
Lumentum
LITE
$75.3B
$8.76M 0.66%
+89,700
New +$8.77M
CCCC icon
52
C4 Therapeutics
CCCC
$422M
$8.64M 0.66%
356,181
+100,500
+39% +$2.44M
WD icon
53
Walker & Dunlop
WD
$1.38B
$8.41M 0.64%
65,010
-25,720
-28% -$3.53M
ISRG icon
54
Intuitive Surgical
ISRG
$133B
$8.33M 0.63%
+27,610
New +$8.07M
HCA icon
55
HCA Healthcare
HCA
$91.8B
$7.87M 0.6%
31,420
-4,850
-13% -$1.22M
KYMR icon
56
Kymera Therapeutics
KYMR
$9.41B
$7.86M 0.6%
185,700
-85,300
-31% -$3.6M
QQQ icon
57
PUT
Invesco QQQ Trust
QQQ
$474B
$7.25M 0.55%
+20,000
New +$7.1M
APLS
58
DELISTED
Apellis Pharmaceuticals
APLS
$7.24M 0.55%
142,409
+10,660
+8% +$471K
ZTS icon
59
Zoetis
ZTS
$30.3B
$7.11M 0.54%
37,681
– –
SYK icon
60
Stryker
SYK
$108B
$6.68M 0.51%
+25,000
New +$6.47M
ABT icon
61
Abbott
ABT
$177B
$5.45M 0.41%
+46,000
New +$5.7M
TMO icon
62
Thermo Fisher Scientific
TMO
$237B
$5.41M 0.41%
9,167
-6,450
-41% -$3.71M
LEGN icon
63
Legend Biotech
LEGN
$3.44B
$4.71M 0.36%
129,691
-65,361
-34% -$2.58M
BBDC icon
64
Barings BDC
BBDC
$914M
$4.59M 0.35%
443,826
-356,090
-45% -$3.82M
HIE
65
DELISTED
Miller/Howard High Income Equity Fund
HIE
$4.54M 0.34%
406,604
+78,900
+24% +$848K
HTZ icon
66
Hertz
HTZ
$688M
$4.44M 0.34%
200,500
+1,600
+0.8% +$33.6K
MRTX
67
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.35M 0.33%
52,902
-47,553
-47% -$4.86M
IRTC icon
68
iRhythm Holdings
IRTC
$3.69B
$4.2M 0.32%
26,695
-68,680
-72% -$8.82M
VCYT icon
69
Veracyte
VCYT
$3.23B
$4.07M 0.31%
147,670
-35,990
-20% -$1.03M
BRW
70
Saba Capital Income & Opportunities Fund
BRW
$319M
$4.07M 0.31%
450,065
+170,971
+61% +$1.53M
BSX icon
71
Boston Scientific
BSX
$63.6B
$3.91M 0.3%
+88,200
New +$3.82M
CMPI
72
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$3.63M 0.28%
1,137,764
-168,862
-13% -$486K
CSCO icon
73
Cisco
CSCO
$434B
$3.55M 0.27%
63,700
– –
LLY icon
74
Eli Lilly
LLY
$1.01T
$3.44M 0.26%
12,013
– –
MCK icon
75
McKesson
MCK
$105B
$3.44M 0.26%
11,232
-62,088
-85% -$16.9M
1 2
3
4 5

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Clough Capital Partners held 150 positions worth $1.32B, down 12% from $1.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Clough Capital Partners withdrew a net $136M in Q1 2022, closing 36 positions and reducing 30 holdings. Its most notable exit was PennyMac Financial, an estimated $79.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Clough Capital Partners opened a new position in NVIDIA worth $31.8M.

  • Clough Capital Partners's largest Q1 2022 buy was NVIDIA: 1,163,700 shares worth $31.8M.
  • Clough Capital Partners added most to Starwood Property Trust in Q1 2022, an estimated $29.1M increase.
  • Clough Capital Partners's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $59.6M.
  • Clough Capital Partners fully exited PennyMac Financial in Q1 2022, selling an estimated $79.8M.
  • Clough Capital Partners's ten largest holdings make up 31% of its $1.32B portfolio in Q1 2022.
  • Clough Capital Partners opened 40 new positions and closed 36 in Q1 2022.
  • Clough Capital Partners's portfolio value fell 12% quarter-over-quarter to $1.32B.

Based on Clough Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.